BIIB Description — Biogen Inc

Biogen is a biopharmaceutical company focused on discovering, developing and delivering therapies for neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Co.'s main growth areas include multiple sclerosis (MS) and neuroimmunology; Alzheimer's disease and dementia; neuromuscular disorders, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis; movement disorders, including Parkinson's disease; ophthalmology; and neuropsychiatry. Co.'s marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; and FUMADERM for the treatment of severe plaque psoriasis.

Company Name: 
Biogen Inc
Number of ETFs Holding BIIB: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   BIIB Weight   BIIB Amount 
 VTI   0.11%   $1,401,396,825         
 VOO   0.13%   $1,025,520,611         
 QQQ   0.35%   $639,358,759         
 SPY   0.13%   $509,055,018         
 IBB   3.79%   $410,510,414         
 IVV   0.13%   $392,844,188         
 VTV   0.29%   $373,954,783         
 XLV   1.00%   $319,651,865         
 MOAT   2.35%   $152,882,452         
 VHT   0.82%   $152,711,431         
List of all 124 ETFs holding BIIB »
Quotes delayed 20 minutes

Buy (2.98 out of 4)
16th percentile
(ranked lower than approx. 84% of all stocks covered)

Analysts Forecast:
BIIB Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding BIIB | Biogen Inc | ETF Channel |

Copyright © 2010 - 2021, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.